Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus bupivacaine + lidocaine for infraclavicular brachial plexus block
IRCT20250422065437N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper extremity fracture comparing Control: bupivacaine with Intervention: bupivacaine + lidocaine (2 arms). Primary endpoints: Onset of complete motor block, Onset of complete sensory block and 2 more. Started Sep 2025; status: completed.
02
Drugs
bupivacainelidocaine
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on IRCT20250422065437N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250422065437N1.